MedPath

Prospective Open Single-Centre Study on the Effect of Initiation of RAD and CNI minimalisation on renal function in heart transplant patients

Conditions
heart transplant patients with impaired renal function under treatment of CNI
Registration Number
EUCTR2005-000222-22-BE
Lead Sponsor
OLV-ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

- age > or = 18 year
- informed consent
- 1 to 10 year heart transplantation
- stable heart allograft function without rejection for at least 12 months
- same IS drugs for at least 6 months
- cyclosporin based IS, with C2 > 300
- poor renal function: eGFR between 25-60 mL/min AND/OR 'creeping creatinin ' i.e. an increase of serum creatinin > 15%/year.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- suspected non-compliance
- intolerance for RAD or STATINS
- life expectancy < 1 year.
- proteinuria > 1.5 g/24h/ 1.73 m²
- previous sirolimus treatment
- obvious other reasons for renal failure

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: to evaluate the evolution of the renal function after initiation of RAD and minimalisation of CNI;Secondary Objective: ;Primary end point(s): renal function
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath